VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
TD Cowen Upgrades Illumina to 'Buy' with Target Price Raised to $144
TD Cowen Upgrades Illumina to 'Buy' with Target Price Raised to $144
Aug 15, 2024 17:47 CST Updated 17:47
Share:
Illumina
Diagnostic Product Developer
Gelonghui August 15 | TD Cowen: Raised the target price of Illumina from $126 to $144, and upgraded the rating from "Hold" to "Buy".